TRICARE also announced that in many instances, beneficiaries will not have to make copayments for certain COVID-19 testing and office visits. The tests must be approved by the Food and Drug Administration (FDA). Beneficiaries who had such tests conducted or made related office visits after March 18 can file a claim for reimbursement for any copayments they may have made.